Bad Odour of sweat and urine
abnormal body odour sweat causes metabolic disorders
abnormal urine odour causes diagnosis
| Food/Substance | Odour Produced |
|---|---|
| Garlic, onions | Sulfurous compounds |
| Cumin, fenugreek | Distinctive pungent odour |
| Alcohol | Acetaldehyde odour |
| Red meat (high intake) | Amplified body odour |
| Condition | Characteristic Sweat Odour |
|---|---|
| Diabetes mellitus (ketoacidosis) | Fruity / acetone smell |
| Phenylketonuria (PKU) | Musty / mousey odour |
| Maple Syrup Urine Disease (MSUD) | Sweet, caramel-like |
| Trimethylaminuria (Fish Odour Syndrome) | Strong fishy smell; due to defective FMO3 enzyme unable to metabolize trimethylamine |
| Isovaleric acidemia | "Sweaty feet" odour (isovaleric acid) |
| Hypermethioninemia | Boiled cabbage smell |
| Liver failure | Musty, ammonia-like ("fetor hepaticus") |
| Renal failure (uremia) | Urine/ammonia-like odour from skin |
| Cause | Odour | Key Features |
|---|---|---|
| UTI (E. coli, Klebsiella) | Foul, ammonia-like | Dysuria, frequency, cloudy urine |
| Dehydration | Concentrated ammonia | Dark yellow urine |
| Diabetes (uncontrolled) | Sweet/fruity | Glycosuria, polyuria, polydipsia |
| Maple Syrup Urine Disease | Sweet, maple syrup | Neonatal onset; elevated branched-chain AAs |
| Phenylketonuria | Musty | Elevated phenylalanine; screened at birth |
| Trimethylaminuria | Fishy | Also affects sweat and breath |
| Isovaleric/Glutaric acidemia | Sweaty feet / pungent | Organic acidurias |
| Liver failure | Ammonia/musty | Jaundice, encephalopathy |
| Fistula (enterovesical) | Feculent (fecal) | Pneumaturia, recurrent UTI |
| Dietary (asparagus, coffee, garlic) | Sulfurous/distinct | Benign, transient |
| Medications (metronidazole, vitamins B) | Metallic/distinct | History of drug use |
| Test | Indication |
|---|---|
| Urinalysis + culture | UTI, glycosuria, ketonuria |
| Blood glucose / HbA1c | Diabetes mellitus |
| Renal function (BUN, creatinine) | Uremia |
| Liver function tests | Liver failure |
| Plasma amino acids / urine organic acids | Metabolic/inborn errors |
| Urine trimethylamine assay | Trimethylaminuria |
| Newborn screening | MSUD, PKU (if not done) |
| Condition | Management |
|---|---|
| Bromhidrosis (local) | Antibacterial soap, antiperspirants (aluminium chloride), topical antibiotics (clindamycin), regular shaving, breathable fabrics |
| Pitted keratolysis | Topical erythromycin or benzoyl peroxide |
| Diabetes (DKA odour) | Insulin, fluid/electrolyte correction |
| UTI | Appropriate antibiotics based on culture |
| Trimethylaminuria | Low-choline diet, riboflavin supplementation, short antibiotic courses to reduce gut flora |
| MSUD/PKU | Specialized dietary restriction (managed by metabolic team) |
| Renal/hepatic failure | Treat underlying disease |
| Dehydration | Adequate fluid intake |
Clinical Pearl: When both sweat and urine share the same abnormal odour, an inborn error of metabolism (MSUD, PKU, isovaleric acidemia, trimethylaminuria) or systemic disease (DKA, renal failure, liver failure) is the most likely underlying cause, rather than a local/hygiene issue.
Diagnostic investigations for all of the above disorders
diagnostic investigations trimethylaminuria phenylketonuria maple syrup urine disease organic acidemia laboratory
urinary tract infection diabetes mellitus renal failure hepatic failure diagnostic workup investigations
| Investigation | Purpose |
|---|---|
| Clinical examination | Identify affected areas (axilla, groin, feet) |
| Wood's lamp (UV) | Coral-red fluorescence → erythrasma |
| Skin swab for culture & sensitivity | Identify causative bacteria (Corynebacterium, Staphylococcus) |
| Sweat chloride test | Rule out cystic fibrosis if recurrent infections |
| Investigation | Details |
|---|---|
| Urine trimethylamine (TMA) assay | Elevated TMA; reduced TMA N-oxide ratio (TMA:TMAO) — gold standard |
| TMA challenge test | 600 mg oral choline load; urine collected at 8 hrs and 24 hrs |
| FMO3 gene sequencing | Identifies causative mutations in the flavin-containing monooxygenase 3 gene |
| Plasma amino acids | Exclude other aminoacidopathies |
| Investigation | Details |
|---|---|
| Newborn screening (Guthrie test / tandem MS) | Elevated phenylalanine on dried blood spot |
| Plasma phenylalanine | >120 µmol/L (classic PKU >1200 µmol/L) |
| Plasma tyrosine | Low (phenylalanine:tyrosine ratio elevated) |
| Urine phenylpyruvic acid (ferric chloride test) | Turns green — historical screening test |
| PAH gene mutation analysis | Confirms diagnosis, guides prognosis & BH4 responsiveness |
| BH4 (sapropterin) loading test | Phenylalanine drop >30% = BH4-responsive PKU |
| Urine pterins + DHPR activity | Rule out BH4 cofactor deficiencies (malignant hyperphenylalaninemia) |
| Investigation | Details |
|---|---|
| Newborn screening (tandem MS) | Elevated leucine, isoleucine, valine (branched-chain amino acids) |
| Plasma amino acids | Elevated branched-chain AAs (leucine most toxic); alloisoleucine is pathognomonic |
| Urine organic acids | Elevated 2-oxoisocaproic, 2-oxoisovaleric acids (branched-chain keto acids) |
| Urine DNPH (dinitrophenylhydrazine) test | Yellow precipitate — keto acids present |
| BCKDHA/BCKDHB/DBT/DLD gene sequencing | Confirms enzymatic defect (BCKAD complex) |
| MRI brain | Diffuse oedema in neonatal crisis; basal ganglia/brainstem involvement |
| Investigation | Details |
|---|---|
| Urine organic acids (GC-MS) | Massively elevated isovalerylglycine and 3-hydroxyisovaleric acid |
| Plasma acylcarnitines (tandem MS) | Elevated C5-acylcarnitine (isovalerylcarnitine) |
| Newborn screening | C5 acylcarnitine elevation |
| IVD gene sequencing | Confirms isovaleryl-CoA dehydrogenase deficiency |
| CBC, ammonia, blood gas | Assess severity (hyperammonemia, metabolic acidosis, neutropenia) |
| Blood glucose | Hypoglycemia in acute crises |
| Investigation | Details |
|---|---|
| Urine organic acids (GC-MS) | Specific organic acid profiles for each disorder |
| Plasma acylcarnitines | Tandem MS; acylcarnitine pattern identifies specific enzyme defect |
| Plasma ammonia | Elevated in crises |
| Blood gas (pH, bicarbonate) | High anion gap metabolic acidosis |
| Gene panel / whole exome sequencing | For atypical or unresolved cases |
| Investigation | Details |
|---|---|
| Random/fasting blood glucose | ≥200 mg/dL (random) or ≥126 mg/dL (fasting) |
| HbA1c | ≥6.5% confirms DM; monitors long-term control |
| Urine/blood ketones | Elevated in DKA (beta-hydroxybutyrate preferred) |
| Arterial blood gas (ABG) | pH <7.3, low bicarbonate (metabolic acidosis) in DKA |
| Serum electrolytes | Anion gap calculation; Na⁺, K⁺ imbalance |
| Serum osmolality | Elevated in hyperosmolar states |
| Urinalysis | Glycosuria, ketonuria |
| C-peptide / insulin levels | Differentiates Type 1 from Type 2 |
| GAD65, IA-2 autoantibodies | Confirm Type 1 DM |
| Investigation | Details |
|---|---|
| Urinalysis (dipstick) | Nitrites, leukocyte esterase, blood, protein |
| Urine microscopy | Pyuria (>5 WBC/hpf), bacteriuria, casts |
| Urine culture & sensitivity (MSU) | Gold standard; identifies organism and antibiotic susceptibility |
| Urine Gram stain | Rapid preliminary identification |
| Blood culture | If systemic sepsis suspected (pyelonephritis, urosepsis) |
| Serum CRP, procalcitonin, WBC | Severity assessment |
| Renal ultrasound | Rule out obstruction, abscess, structural anomaly |
| CT urogram | Recurrent/complicated UTI; stones, fistulae |
| Cystoscopy | Recurrent UTI; rule out bladder pathology |
| Investigation | Details |
|---|---|
| Urine culture | Mixed organisms (colonic flora: E. coli, Bacteroides, anaerobes) |
| CT abdomen/pelvis with contrast | Best initial test; identifies fistula tract, underlying cause |
| Cystoscopy | Direct visualization of fistula opening in bladder |
| Colonoscopy / barium enema | Identify bowel source (Crohn's, diverticulitis, carcinoma) |
| Poppy seed test | Oral poppy seeds appear in urine within 24–48 hrs (low-tech confirmation) |
| Investigation | Details |
|---|---|
| Serum creatinine & BUN | Elevated; BUN:creatinine ratio assessment |
| eGFR (CKD-EPI formula) | Staging of chronic kidney disease |
| Urinalysis | Proteinuria, haematuria, casts (granular/waxy in CKD) |
| Urine protein:creatinine ratio | Quantify proteinuria |
| Serum electrolytes | Hyperkalemia, metabolic acidosis, hyperphosphatemia |
| CBC | Normocytic anaemia (reduced EPO) |
| PTH, calcium, phosphate | Renal osteodystrophy assessment |
| Renal ultrasound | Small echogenic kidneys (CKD) vs. large (DM, myeloma, ADPKD) |
| Renal biopsy | For unexplained/atypical AKI or glomerulonephritis |
| Investigation | Details |
|---|---|
| Liver function tests (LFTs) | Elevated AST, ALT, ALP, GGT; low albumin; prolonged PT/INR |
| Serum ammonia | Elevated in hepatic encephalopathy |
| Serum bilirubin (total/direct) | Elevated in cholestasis/hepatocellular failure |
| Prothrombin time / INR | Coagulation factor synthesis reflects liver function |
| Serum albumin | Marker of synthetic function (chronic liver disease) |
| CBC | Thrombocytopenia (portal hypertension/hypersplenism) |
| Hepatitis serology | HBsAg, anti-HCV, HAV IgM |
| Autoimmune markers | ANA, ASMA, AMA, anti-LKM1 (autoimmune hepatitis, PBC) |
| Ceruloplasmin + 24-hr urine copper | Wilson's disease (especially young patients) |
| Alpha-1-antitrypsin levels | A1AT deficiency |
| Abdominal ultrasound + Doppler | Liver size, texture, portal hypertension, ascites |
| Fibroscan (elastography) | Non-invasive liver fibrosis staging |
| Liver biopsy | Definitive histological diagnosis |
| Investigation | Details |
|---|---|
| Plasma amino acids | Elevated methionine |
| Plasma homocysteine | Distinguish MAT I/III deficiency from homocystinuria |
| Urine organic acids | Elevated methionine metabolites |
| MAT1A gene sequencing | Methionine adenosyltransferase deficiency |
| Disorder | First-Line | Second-Line / Confirmatory |
|---|---|---|
| Bromhidrosis | Clinical + Wood's lamp + swab | Culture & sensitivity |
| Trimethylaminuria | Urine TMA/TMAO ratio | FMO3 gene sequencing |
| PKU | Newborn screen / plasma Phe | PAH gene sequencing, BH4 test |
| MSUD | Plasma AAs (alloisoleucine) | Urine organic acids, gene panel |
| Isovaleric acidemia | Urine organic acids, acylcarnitines | IVD gene sequencing |
| DM/DKA | Blood glucose, ketones, ABG | HbA1c, autoantibodies |
| UTI | Urinalysis, urine culture | Imaging, cystoscopy |
| Enterovesical fistula | CT abdomen/pelvis | Cystoscopy, colonoscopy |
| Renal failure | Creatinine, eGFR, urinalysis | Renal biopsy, ultrasound |
| Liver failure | LFTs, ammonia, INR | Hepatitis serology, biopsy |
| Hypermethioninemia | Plasma amino acids | Gene sequencing |
Clinical Tip: For any child or neonate presenting with unusual odour, the first-line investigation is plasma amino acids + urine organic acids + tandem mass spectrometry-based acylcarnitine profile — this single panel can identify most inborn errors of metabolism simultaneously.